Best Practices for Effective PI Compensation

Complion fREE Educational Webinar

Wednesday, October 25th, 2017 | 1:00 – 2:00 PM ET

Presented by: David B, Russell. Director of Site Strategy, PFS Clinical.

As research funds are becoming increasingly competitive, a frequent question asked is, “How much should we pay investigators for their work on a clinical trial and what methodology should be used?”. While the question may seem straightforward, it is far more complex and potentially volatile under the surface. The amount and the method by which you use to pay investigators can play a big role in the success, or lack thereof, of your site.

Join PFS Clinical’s Director of Site Strategy, David B. Russell, for an educational webinar on PI Compensation. During this webinar, David will discuss the regulation considerations when setting compensation amounts, the pros and cons of different PI compensation models, and investigator agreement considerations.

Specific areas covered include:

  •  Pros and cons of different PI payment models
  • Investigator agreement considerations
  • Considerations for compliant documentation

Register now!

This webinar is hosted by Complion. Complion will provide all registered attendees with a certificate of attendance for self-reporting continuing education credits, within 72 hours of the live presentation. 


About the Presenter

David Russell.pngDavid B, Russell. Director of Site Strategy, PFS Clinical.

David B. Russell has over twenty-four years of experience in the healthcare industry, the last twelve of which have been specifically focused on clinical research. He currently serves as Director of Site Strategy for PFS Clinical where he oversees accounts utilizing multiple administrative services that PFS Clinical offers.

Mr. Russell has extensive experience in the areas of study start-up, financial reporting, investigator compensation, budget/contract negotiations, coverage analysis, research billing adjudication, and process improvement. David has been instrumental in the building, restructuring, and turnaround of numerous research sites across the country.